Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00968513 · ClinicalTrials.gov registry record · NA

Evaluation of Tobacco Treatment Strategies for Inpatient Psychiatry

A NA study of Tobacco Dependence, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
956
Enrollment target
3
Study locations

NCT00968513: Completed NA study of Tobacco Dependence, sponsored by Stanford University.

NCT00968513 is a NA study of Tobacco Dependence that has completed, run by Stanford University. The registered enrollment target is 956 participants, above the 445-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (115% higher). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00968513, a NA study of Tobacco Dependence, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
956 participants
Enrollment target
3
Study locations

Study Summary

This study aims to evaluate, in a randomized controlled trial, tobacco treatments of varying intensities for smokers hospitalized on acute psychiatric inpatient units.

Primary Outcome

Number of Participants who Quit Smoking at 3, 6, 12, and 18 Months

Conditions Studied

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL Brief Intervention
  • BEHAVIORAL Extended Treatment

Study Locations (3)

California

  • Alta Bates Summit Medical Center - Berkeley
  • UCSF Langley Porter Psychiatric Institute - San Francisco
  • Stanford Hospital and Clinics - Stanford

Trial Details

FieldValue
Enrollment Target 956 participants
Start Date 2009-09
Est. Completion 2015-06
Phase NA
Stanford University

1,744 total trials

What the finished NCT00968513 record still lists

NCT00968513 is an interventional study that assigns participants to a tested intervention. The registered 956 participants enrollment target is mid-sized for trials with a published cap, above the 445-participant average among 28 other Tobacco Dependence trials with a reported enrollment target (115% higher).

The record links to 1 condition, with Tobacco Dependence appearing as the primary indexed condition, and to 3 interventions - of which Usual Care is the first listed.

NCT00968513 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00968513 about?

NCT00968513 is a clinical study titled "Evaluation of Tobacco Treatment Strategies for Inpatient Psychiatry". This study aims to evaluate, in a randomized controlled trial, tobacco treatments of varying intensities for smokers hospitalized on acute psychiatric inpatient units.

What is the current status of trial NCT00968513?

This trial is currently completed. It is a NA study. The enrollment target is 956 participants. The study started on 2009-09. Estimated completion is 2015-06.

What conditions does trial NCT00968513 study?

This clinical trial studies the following conditions: Tobacco Dependence.

What interventions are being tested in trial NCT00968513?

The interventions under investigation include: Usual Care (BEHAVIORAL), Brief Intervention (BEHAVIORAL), Extended Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT00968513?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00968513 being conducted?

This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00968513's enrollment target sits among peer trials

956 4th of 28 higher than 25 of 28 other Tobacco Dependence trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tobacco Dependence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06225596 · 956 participants · Phase 2

    Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

  • NCT06259669 · 958 participants

    Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population

  • NCT04726241 · 960 participants · Phase 1

    The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • NCT05142384 · 960 participants · NA

    ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00968513, the US trial registry maintained by the National Library of Medicine. NCT00968513 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.